Original language | English |
---|---|
Pages (from-to) | 2586-2591 |
Journal | Blood |
Volume | 115 |
Issue number | 13 |
DOIs | |
Publication status | Published - 1 Apr 2010 |
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
Bob Lowenberg, Joachim Beck, Carlos Graux, Wim van Putten, Harry C. Schouten, Leo F. Verdonck, Augustin Ferrant, Pieter Sonneveld, Mojca Jongen-Lavrencic, Marie von Lilienfeld-Toal, Bart J. Biemond, Edo Vellenga, Dimitri Breems, Hilde de Muijnck, M Ron Schaafsma, Gregor E. G. Verhoef, Hartmut Doehner, Alois Gratwohl, Thomas Pabst, Gert Jan Ossenkoppele
Research output: Contribution to journal › Article › Academic › peer-review